Last viewed: PLRX


Prices are updated after-hours



nasdaq:PLRX Pliant Therapeutics, Inc.

PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-12.3% 1m) (-58.8% 1y) (0.0% 2d) (0.0% 3d) (-2.0% 7d) (-30.91% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 753,290,896

http://www.pliantrx.com
Sec Filling | Patents | 62 employees


(US) Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.



add to watch list Paper trade email alert is off

Press-releases


Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight
Published: 2024-04-03 (Crawled : 22:00) - prnewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 1.87% H: 3.4% C: -1.02%

fibrosis therapeutics growth market
Pliant Therapeutics to Participate in Upcoming Investor Events
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 1.17% C: 1.17%

therapeutics
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Published: 2024-03-27 (Crawled : 14:30) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 1.34% H: 3.63% C: 1.54%

conference international therapeutics
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 6.88% C: 4.2%

treatment fibrosis bexotegrast therapeutics
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 6.88% C: 4.2%
MRKR | $4.43 5.73% 5.42% 12K twitter stocktwits trandingview |
Consumer Services
| | O: -1.2% H: 4.88% C: 3.17%

therapeutics
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 4.59% H: 0.0% C: -7.67%

update therapeutics financial results
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 4.27% C: 1.4%

therapeutics
Pliant Therapeutics to Participate in Upcoming Investor Events - February 7, 2024
Published: 2024-02-07 (Crawled : 15:00) - biospace.com/
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.93% C: -0.87%

therapeutics
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2024-02-04 (Crawled : 00:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -5.78%

liver positive fibrosis bexotegrast trial therapeutics
Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 13:00) - globenewswire.com
PLRX | $12.505 -0.75% -0.76% 240K twitter stocktwits trandingview |
Health Technology
| | O: 0.28% H: 3.44% C: 0.28%

conference therapeutics
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K twitter stocktwits trandingview |
| 00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K twitter stocktwits trandingview |
Retail Trade
| 22:00
CONN | $3.71 1.37% 1.35% 72K twitter stocktwits trandingview |
Retail Trade
| 21:30
TGEN P 6000 | $0.6897 39.71% 2.3K twitter stocktwits trandingview |
Utilities
| 18:30
CMTV P 700 | $15.74 17.43% 12K twitter stocktwits trandingview |
Finance and Insurance
| 18:30
FNB | $13.63 2.17% 0.0% 2.5M twitter stocktwits trandingview |
Finance
| 17:30
RMCF | $3.57 0.28% 2.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar